reviewTop 1% cited
HDAC family: What are the cancer relevant targets?
Cancer Letters · 2008 · Vol. 277(1) · pp. 8–21
Olaf Witt✉(Heidelberg University)Hedwig E. Deubzer(Heidelberg University)Till Milde(University Hospital Heidelberg)Ina Oehme(Heidelberg University)
Histone Deacetylase Inhibitors ResearchPeptidase Inhibition and AnalysisProtein Degradation and InhibitorsCancerBiologyGene familyCancer cellPhenotypeEpigeneticsHistone deacetylaseCancer researchGeneticsGene
MeSH terms
AnimalsAntineoplastic AgentsEnzyme InhibitorsHistone DeacetylasesHumansNeoplasmsPolymorphism, GeneticHistone Deacetylase Inhibitors
Funding
- Bundesministerium für Bildung und Forschung
Citations
1,047
FWCI
14.62
field-weighted impact
References
131
Percentile
99%
vs. same field & year
Citations per year
Cited by
Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids
European Journal of Medicinal Chemistry · 2014 · 426 citations
References
Anticancer activities of histone deacetylase inhibitors
Nature Reviews Drug Discovery · 2006 · 2,905 citations
Quantitation of HDAC1 mRNA Expression in Invasive Carcinoma of the Breast*
Breast Cancer Research and Treatment · 2005 · 306 citations
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
Nature reviews. Cancer · 2006 · 2,190 citations
Histone deacetylases (HDACs): characterization of the classical HDAC family
Biochemical Journal · 2003 · 3,077 citations
A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas
Leukemia · 2008 · 439 citations
Class II histone deacetylases: versatile regulators
Trends in Genetics · 2003 · 655 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.